Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes

Details for Australian Patent Application No. 2012201727 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012201727

Parent 2008202638

Filing date 22 March 2012

Wipo publication date 12 April 2012

International Classifications

A61K 31/454 (2006.01)

A61K 31/07 (2006.01)

A61K 31/285 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/573 (2006.01)

A61K 31/724 (2006.01)

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

5 April 2012 Complete Application Filed

12 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201727

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201728-Vibratory milling machine having linear reciprocating motion

2012201726-Surgical fluid management